Epigenetic effects of green tea polyphenols in cancer

Susanne M Henning1, Piwen Wang, Catherine L Carpenter

  • 1Center for Human Nutrition, David Geffen School of Medicine, University of California Los Angeles, 900 Veteran Avenue, Warren Hall 14-166, Los Angeles, CA 90095, USA.

Epigenomics
|November 29, 2013
PubMed

Insights

Green tea compounds like epigallocatechin gallate may prevent cancer by altering DNA methylation. This review explores green tea's potential to modify epigenetic processes for chemoprevention.

Area of Science:

  • Epigenetics and molecular biology
  • Nutritional science and cancer chemoprevention

Background:

  • Epigenetics involves heritable changes in gene expression without altering DNA sequence.
  • DNA methylation (hyper- and hypomethylation) influences gene expression and carcinogenesis.
  • Epigenetic modifications are reversible and potentially targetable by diet.

Purpose of the Study:

  • To review the potential of green tea (GT) to modify epigenetic processes.
  • To explore the role of GT in cancer chemoprevention through epigenetic mechanisms.

Main Methods:

  • Review of existing literature on green tea, epigenetics, and cancer.
  • Analysis of studies on (-)-epigallocatechin gallate (EGCG) and DNA methyltransferase activity.
  • Examination of animal models and human studies investigating GT consumption and epigenetic markers.

Main Results:

  • (-)-Epigallocatechin gallate (EGCG) from green tea alters DNA methyltransferase activity in various cancer cells.
  • Evidence from mouse models suggests EGCG inhibits DNA methylation.
  • Human studies link higher green tea consumption to decreased CDX2 and BMP-2 methylation in gastric cancer.

Conclusions:

  • Green tea possesses potential epigenetic modulatory effects relevant to cancer chemoprevention.
  • Dietary interventions, specifically green tea consumption, may offer a strategy to influence epigenetic processes for cancer prevention.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K